BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

Korro Bio

Korro Bio logo

Patents
19
Publications
1

Technologies

RNA-focused Startups

At Korro Bio our aim is to bring transformative treatments to patients with rare and debilitating diseases by addressing the underlying genetic cause. We are utilizing the precision provided by nucleic acid-based therapeutics to target the sequences responsible within the genetic code.


Posts Mentioning This Company

6 Promising RNA Biotech Companies To Watch in 2024

  
For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there is a completely different level of cell regulation – transcriptome level, presented by Ribonucleic acids (RNAs). RNA molecules are not just intermediates between DNA and proteins, in fact, they also carry …

Top Companies At The Forefront Of RNA Therapeutics Development

  
Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs in the field of RNA-targeting medicines, primarily falling into the following two categories: antisense oligonucleotides (ASO), and RNA interference (RNAi) technologies. (another promising approach, dealing with editing RNA itself by …

A Race For Better Gene Editing Tech Is On

  
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least in research laboratories, where scientists efficiently adopted CRISPR technology to manipulate genes of interest. Still, applying it for humans is associated with greater risks and faces ethical issues. However, alongside …